Psilos Group

Psilos Group is a venture capital firm established in 1998. The firm was founded by Stephen M. Krupa. Psilos Group is headquartered in New York City, United States. It specializes in providing capital for companies at the growth and expansion stages. Psilos Group focuses on funding companies operating in the healthcare sector, which spans from diagnostic equipments to healthcare enterprise systems. As of September 2017, the firm is managing eight active companies in its portfolio, and has sold off its stakes in 34 companies.

Psilos Group is a venture capital firmventure capital firm established in 1998. The firm was founded by Stephen M. Krupa. Psilos Group is headquartered in New York City, United States. It specializes in providing capital for companies at the growth and expansion stages. Psilos Group focuses on funding companies operating in the healthcare sector, which spans from diagnostic equipments to healthcare enterprise systems. As of September 2017, the firm is managing eight active companies in its portfolio, and has sold off its stakes in 34 companies.

Psilos Group is a venture capital firm established in 1998. The firm was founded by Stephen M. Krupa. Psilos Group is headquartered in New York CityNew York City, United States. It specializes in providing capital for companies at the growth and expansion stages. Psilos Group focuses on funding companies operating in the healthcare sector, which spans from diagnostic equipments to healthcare enterprise systems. As of September 2017, the firm is managing eight active companies in its portfolio, and has sold off its stakes in 34 companies.

Psilos Group is a venture capital firm established in 1998. The firm was founded by Stephen M. Krupa. Psilos Group is headquartered in New York City, United States. It specializes in providing capital for companies at the growth and expansion stages. Psilos Group focuses on funding companies operating in the healthcare sector, which spans from diagnostic equipments to healthcare enterprise systems. As of September 2017, the firm is managing eight active companies in its portfolio, and has sold off its stakes in 34 companies.